v3.26.1
Consolidated Statements of Changes in Shareholders' Equity
$ in Thousands, $ in Thousands
Common Shares
USD ($)
shares
Pre-Funded Warrants
USD ($)
shares
Contributed Surplus
USD ($)
Accumulated Deficit
USD ($)
Accumulated Other Comprehensive Loss
USD ($)
USD ($)
CAD ($)
Balance - at beginning (in shares) (Notes 2 and 19) at Dec. 31, 2023 | shares [1] 112,791,658 39,702,780          
Balance - at beginning (Notes 2 and 19) at Dec. 31, 2023 $ 47,335 $ 13,050 $ 6,472 $ (36,463) $ 362 $ 30,756 $ 40,674
Consolidated Statements of Changes in Shareholders' Equity              
Exercise of warrants (in shares) (Note 9) | shares [1] 1,608,214            
Exercise of warrants (Note 9) $ 813   (213)     600  
Equity issued in equity offering, net of transaction costs (in shares) | shares [1] 51,420,000 11,865,000          
Equity issued in equity offering, net of transaction costs $ 29,983 $ 6,917       29,983  
Stock-based compensation (Note 10)     1,641     1,641  
Net loss for the year       (20,634)   (20,634) (28,099)
Foreign currency translation adjustment         (2,099) (2,099) (202)
Balance - at end (in shares) at Dec. 31, 2024 | shares [1] 165,819,872 51,567,780          
Balance - at end at Dec. 31, 2024 $ 78,131 $ 19,967 7,900 (57,097) (1,737) 47,164 $ 67,862
Consolidated Statements of Changes in Shareholders' Equity              
Exercise of warrants (in shares) (Note 9) | shares [1] 5,623,087            
Exercise of warrants (Note 9) $ 2,928   (834)     2,094  
Common Shares issued in connection with the exercise of Pre-Funded Warrants (in shares) (Note 8) | shares [1] 13,650,631 (13,650,840)          
Common Shares issued in connection with the exercise of Pre-Funded Warrants (Note 8) $ 4,487 $ (4,487)          
Common Shares issued upon exercise of stock options (in shares) | shares [1] 413,563            
Common Shares issued upon exercise of stock options $ 282   (135)     147  
Stock-based compensation (Note 10)     3,235     3,235  
Net loss for the year       (24,873)   (24,873)  
Foreign currency translation adjustment         17 17  
Balance - at end (in shares) at Dec. 31, 2025 | shares [1] 185,507,153 37,916,940          
Balance - at end at Dec. 31, 2025 $ 85,828 $ 15,480 $ 10,166 $ (81,970) $ (1,720) $ 27,784  
[1] Presented on a pre-consolidation basis, unadjusted for the twelve-for-one share consolidation completed on January 27, 2026 (note 8)